QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 24, 2002

Specialty Laboratories, Inc.
(Exact name of registrant as specified in charter)


California

 

001-16217

 

95-2961036
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

       


2211 Michigan Avenue, Santa Monica, California

 

90404
(Address of principal executive offices)   (Zip Code)

Registrant's telephone number, including area code (310) 828-6543

(Former name or former address, if changed since last report.)





ITEM 5    OTHER EVENTS

        On June 24, 2002 Specialty Laboratories, Inc., (the "Registrant") announced the appointment of Terrance H. Gregg to the Registrant's Board of Directors. Gregg is currently President of Medtronic MiniMed. He replaces Paul F. Beyer who resigned as a Director.

        A copy of the press release issued by the Registrant on June 24, 2002 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.


ITEM 7    FINANCIAL STATEMENTS AND EXHIBITS

(c)   Exhibits   The following document is filed as an exhibit to this report:

 

 

99.1

 

Press Release dated June 24, 2002.

2



SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    Specialty Laboratories, Inc.

Date: June 26, 2002

 

By:

 

/s/  
FRANK J. SPINA      
Frank J. Spina,
Chief Financial Officer


EXHIBIT INDEX

Exhibits   The following document is filed as an exhibit to this report:

99.1

 

Press Release dated June 24, 2002.



QuickLinks

ITEM 5 OTHER EVENTS
ITEM 7 FINANCIAL STATEMENTS AND EXHIBITS
SIGNATURE
EXHIBIT INDEX